Company Filing History:
1 out of 49 
1 out of 60 
1 out of 5 Years Active: 2015
Title: **Innovator Yuuka Hirao: Pioneering Advances in Neuroscience**
Introduction
Yuuka Hirao, an accomplished inventor located in Yokohama, Japan, has made significant contributions to the field of neuroscience through her innovative research and patenting efforts. With one patent to her name, Hirao's work focuses on addressing critical health issues associated with abnormal gene expression in the nervous system.
Latest Patents
Hirao's notable patent is titled "Use of compound binding to mSin3B that specifically binds to neuron restrictive silencer factor (NRSF)." This invention identifies a compound capable of binding to the PAH1 domain of mSin3B, which has a direct association with neural restrictive silencer factor NRSF. The patent aims to provide a prophylactic and therapeutic solution for diseases linked to abnormal expressions, such as Huntington's disease, medulloblastoma, and neuropathic pain. The pharmaceutical composition detailed in the patent includes various components capable of effectively binding to the respective targets, offering hope for future treatments.
Career Highlights
Hirao has collaborated with leading research institutions, notably Public University Corporation Yokohama City University and Nagasaki University, which have fostered her growth as a researcher and inventor. This career trajectory highlights her dedication to advancing medical science through her innovative endeavors.
Collaborations
Throughout her career, Hirao has worked alongside fellow researchers Yoshifumi Nishimura and Aritaka Nagadoi. These collaborations have enhanced her research capabilities and contributed to the impactful discoveries she has made in the field.
Conclusion
Yuuka Hirao's groundbreaking work in the clinical application of compound binding offers promising avenues for addressing serious neurological conditions. Her commitment to innovation and collaboration underscores her importance in the scientific community, paving the way for future advancements in therapeutics targeting gene expression related issues.